Literature DB >> 18488964

Dose reduction from loss of backscatter in superficial x-ray radiation therapy with the Pantak SXT 150 unit.

B J Healy1, S Sylvander, K N Nitschke.   

Abstract

Loss of backscatter has been measured for a Pantak Therapax SXT 150 superficial x-ray therapy unit. Ionisation chamber measurements at the surface were performed in solid water with and without underlying lead to confirm the applicability of previous published measurements. Measurements of loss of backscatter with and without lead allowed the effect of underlying lead to be separated from the effect of loss of backscatter. It was found that the difference between the effect of lead and that of air on surface dose is minimal for solid water phantom thickness exceeding 3 cm. Differences up to 3% in dose reduction at the surface were found between this work and previous published results with different x-ray units.

Entities:  

Mesh:

Year:  2008        PMID: 18488964     DOI: 10.1007/BF03178453

Source DB:  PubMed          Journal:  Australas Phys Eng Sci Med        ISSN: 0158-9938            Impact factor:   1.430


  4 in total

1.  Effect of the bone heterogeneity on the dose prescription in orthovoltage radiotherapy: A Monte Carlo study.

Authors:  James C L Chow; Grigor N Grigorov
Journal:  Rep Pract Oncol Radiother       Date:  2011-11-15

Review 2.  Review of backscatter measurement in kilovoltage radiotherapy using novel detectors and reduction from lack of underlying scattering material.

Authors:  David J Eaton; Paul J Doolan
Journal:  J Appl Clin Med Phys       Date:  2013-11-08       Impact factor: 2.102

3.  Surface dose reduction from bone interface in kilovoltage X-ray radiation therapy: a Monte Carlo study of photon spectra.

Authors:  James C L Chow; Amir M Owrangi
Journal:  J Appl Clin Med Phys       Date:  2012-09-06       Impact factor: 2.102

4.  The effect of the horizontal metallic drive on reference dosimetry in the SNC 3D scanner water tank.

Authors:  Sadia Aftab; Michael P Barnes; Marcus Doebrich; Joerg Lehmann
Journal:  J Appl Clin Med Phys       Date:  2020-04-01       Impact factor: 2.102

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.